Naoky Tsai, MD

Articles by Naoky Tsai, MD

Changing Demographics Among Populations Prescribed HCV Treatment, 2013-2017

ByNaoky Tsai, MD,Bruce Bacon, MD,Michael Curry, MD,Steven L. Flamm, MD,Scott Milligan, PhD,Nicole Wick, AS,Zobair Younossi, MD,Nezam Afdhal, MD

July 12th 2019

From 2013 to 2017, the population of US patients prescribed treatment for chronic hepatitis C virus (HCV) changed, becoming predominantly treatment-naïve and having received care in nonacademic centers.

Latest Updated Articles

Changing Demographics Among Populations Prescribed HCV Treatment, 2013-2017
July 12th 2019

Naoky Tsai, MD

Articles by Naoky Tsai, MD

Changing Demographics Among Populations Prescribed HCV Treatment, 2013-2017

Latest Updated Articles

Trending on AJMC

Special Report: The Oncology Care Model, 10 Years Later

FDA Approves Tocilizumab-bavi for CAR-T-Induced CRS, Pediatric COVID-19

AI Model Challenges Genomic Classifiers in Early Breast Cancer Risk Stratification: Nancy Lin, MD

Weight Loss Drugs Can Improve Outcomes in Patients With Heart Failure and Obesity: Sandra Chaparro, MD

Shields Health Solutions Partners With Baptist Health on Specialty Pharmacy